Related Experiment Video
Updated: Jan 8, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
22.2K
Predicting dementia risk using neuroimaging and cognitive assessment
Yu Wang1, William Guiler2, Ankit Patel2
1Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA.
JAR Life
|December 22, 2025
Summary
Combining brain imaging with cognitive tests improves dementia risk prediction. This multimodal approach offers a scalable method for early detection and personalized care in aging populations.
Area of Science:
- Neuroscience
- Gerontology
- Medical Imaging
Background:
- Dementia affects over 55 million globally, with numbers projected to double.
- Current dementia risk assessments often fall short, necessitating improved early detection methods.
- Integrating structural brain imaging with cognitive assessments may enhance dementia risk prediction accuracy.
Purpose of the Study:
- To evaluate the efficacy of combining structural brain imaging and brief cognitive assessments for predicting dementia risk.
- To compare the predictive power of single-visit versus longitudinal modeling approaches.
- To identify key neuroimaging and cognitive markers associated with dementia risk.
Main Methods:
- Utilized data from 312 older adults from the KU Alzheimer's Disease Center cohort.
- Employed cognitive testing and MRI scans measuring hippocampal volume, gray matter, and Alzheimer's disease signature regions.
- Assessed depressive symptoms using the Geriatric Depression Scale (GDS) and analyzed both single-visit and longitudinal data.
Main Results:
- Multimodal models incorporating neuroimaging significantly outperformed those relying solely on demographics or cognitive scores.
- The optimal model, combining imaging and cognitive data, achieved 77.6% accuracy in predicting dementia status.
- Reduced hippocampal volume, lower gray matter, and higher GDS scores were identified as key predictors, suggesting an interaction between depression and neurodegeneration.
Conclusions:
- A compact, multimodal approach using standard MRI and brief cognitive tests can generate clinically relevant individualized dementia risk profiles.
- This method provides a scalable pathway for early intervention, clinical trial enrollment, and personalized care planning.
- Future research will focus on diverse population validation and integration of fluid biomarkers to refine dementia risk prediction.
Related Concept Videos
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

